about
Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemiviba...
Read More
0.98
-0.04
(-3.92%)
5.1M
XNAS Volume
XNAS 22 Sep, 2026 2:00 PM (EDT)
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution
View Similar
Embed DVM
Invivyd Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..